Molecular and Cellular Pathobiology Microrna Signature and Expression of Dicer and Drosha Can Predict Prognosis and Delineate Risk Groups in Neuroblastoma

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Lancet

  2021cited by this paper
• DICER1 Mutations in Familial Pleuropulmonary Blastoma

  2009cited by this paper
• Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival

  2009cited by this paper
• Widespread deregulation of microRNA expression in human prostate cancer

  2008cited by this paper
• Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM

  2008cited by this paper
• Observation of peptide differences between cancer and control in gastric juice

  2008cited by this paper
• Impaired microRNA processing enhances cellular transformation and tumorigenesis

  2007cited by this paper
• Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification

  2007cited by this paper
• MicroRNA: Potential for Cancer Detection, Diagnosis, and Prognosis.

  2007cited by this paper
• Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels

  2007cited by this paper
• Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.

  2007cited by this paper
• Specific microRNAs are downregulated in human thyroid anaplastic carcinomas

  2007cited by this paper
• Human p16γ, a novel transcriptional variant of p16INK4A, coexpresses with p16INK4A in cancer cells and inhibits cell-cycle progression

  2007cited by this paper
• Overexpression of Dicer in precursor lesions of lung adenocarcinoma.

  2007cited by this paper
• Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression

  2007cited by this paper
• Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease.

  2007cited by this paper
• The role of microRNAs in cancer: no small matter.

  2007cited by this paper
• microRNAs exhibit high frequency genomic alterations in human cancer.

  2006cited by this paper
• Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.

  2006cited by this paper
• Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma.

  2006cited by this paper
• RNASEN Regulates Cell Proliferation and Affects Survival in Esophageal Cancer Patients

  2006cited by this paper
• Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma.

  2006cited by this paper
• The MYCN enigma: significance of MYCN expression in neuroblastoma.

  2006cited by this paper
• Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.

  2006cited by this paper
• MicroRNA gene expression deregulation in human breast cancer.

  2005cited by this paper
• MicroRNA biogenesis: coordinated cropping and dicing

  2005cited by this paper
• MicroRNA biogenesis and cancer.

  2005cited by this paper
• Real-time expression profiling of microRNA precursors in human cancer cell lines

  2005cited by this paper
• Diversity in neuroblastomas and discrimination of the risk to progress.

  2005cited by this paper
• Neural networks and belief logic

  2004cited by this paper
• Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling

  2004cited by this paper
• Neuroblastoma: biological insights into a clinical enigma

  2003cited by this paper
• Diagnosis of multiple cancer types by shrunken centroids of gene expression

  2002cited by this paper
• Loss of heterozygosity for chromosome 14q in neuroblastoma.

  2001cited by this paper
• Frequent deregulation of p16 and the p16/G1 cell cycle‐regulatory pathway in neuroblastoma

  1999cited by this paper
• The international neuroblastoma risk groups (INRG): a preliminary report

  1997cited by this paper
• Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

  1984cited by this paper

• Regulation and dysregulation of microRNA - transcription factor axes in differentiation and neuroblastoma

  2025cites this paper
• microRNA involvement in human cancer.

  2025cites this paper
• Recent Advances in Pineoblastoma Research: Molecular Classification, Modelling and Targetable Vulnerabilities

  2025cites this paper
• The roles of miR-383 as a diagnostic and prognostic biomarker in human cancers

  2024cites this paper
• Promotor methylation in ocular surface squamous neoplasia development: epigenetics implications in molecular diagnosis

  2023cites this paper
• miRNA-Based Technologies in Cancer Therapy

  2023cites this paper
• Pan-Cancer Study on Variants of Canonical miRNA Biogenesis Pathway Components: A Pooled Analysis

  2023cites this paper
• miRNA dosage control in development and human disease.

  2023cites this paper
• The clinical utility of dysregulated microRNA expression in paediatric solid tumours.

  2022cites this paper
• Clinical implications of noncoding RNAs in neuroblastoma patients

  2022cites this paper
• Genetics and epigenetics in conventional chondrosarcoma with focus on non-coding RNAs.

  2022cites this paper
• The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targets

  2022cites this paper
• Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment

  2021cites this paper
• Tumor evolution selectively inactivates the core microRNA machinery for immune evasion

  2021cites this paper
• Development and Validation of a Five-RNA–Based Signature and Identification of Candidate Drugs for Neuroblastoma

  2021cites this paper
• Classical and noncanonical functions of miRNAs in cancers.

  2021cites this paper
• The Role of MicroRNAs in Therapeutic Resistance of Malignant Primary Brain Tumors

  2021cites this paper
• Identification and Validation of a Novel RNA-Binding Protein-Related Gene-Based Prognostic Model for Multiple Myeloma

  2021cites this paper
• microRNAs and bone tumours: role of tiny molecules in the development and progression of chondrosarcoma, of giant cell tumour of bone and of Ewing sarcoma.

  2021cites this paper
• Micro-RNA: The darkhorse of cancer.

  2021cites this paper
• Low Expression of IL-15 and NKT in Tumor Microenvironment Predicts Poor Outcome of MYCN-Non-Amplified Neuroblastoma

  2021cites this paper
• Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma

  2021cites this paper
• Evaluation of the clinical significance of RNase III enzyme DROSHA in pediatrics acute lymphocytic leukemia

  2021cites this paper
• A Positive Feedback Loop Between DICER1 and Differentiation Transcription Factors Is Important for Thyroid Tumorigenesis

  2020cites this paper
• Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma

  2020cites this paper
• Modulating microRNA Processing: Enoxacin, the Progenitor of a New Class of Drugs

  2020cites this paper
• A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies

  2020cites this paper
• A novel risk signature that combines 10 long noncoding RNAs to predict neuroblastoma prognosis

  2020cites this paper
• microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis

  2020cites this paper
• Dysregulation of the miRNA biogenesis components DICER1, DROSHA, DGCR8 and AGO2 in clear cell renal cell carcinoma in both a Korean cohort and the cancer genome atlas kidney clear cell carcinoma cohort.

  2019cites this paper
• MICRO-RNA AS THERAPEUTIC TARGETS FOR NEUROBLASTOMAS

  2019cites this paper
• Small RNA proteome as disease biomarker: An incognito treasure of clinical utility

  2019cites this paper
• Stem Cell-Derived Platelets

  2019cites this paper
• Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases

  2019cites this paper
• Nanotechnologoical based miRNA intervention in the therapeutic management of neuroblastoma.

  2019cites this paper
• Regulatory and therapeutic potential for obesity

  2019cites this paper
• p53, stem cell biology and childhood blastomas

  2019cites this paper
• Application of induced pluripotent stem cells to primary immunodeficiency diseases.

  2019cites this paper
• miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma

  2019cites this paper
• Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma

  2019cites this paper
• Epigenetics in cancer therapy and nanomedicine

  2019cites this paper
• Микро-РНК как терапевтические мишени при нейробластомах

  2019cites this paper
• miR‐122 promotes metastasis of clear‐cell renal cell carcinoma by downregulating Dicer

  2018cites this paper
• CHARACTERIZING THE ROLE OF MIRNA IN CANCER WITH SPECIAL REFERENCE TO BREAST CANCER, LUNG CANCER AND COLORECTAL CANCER

  2018cites this paper
• Regulation of microRNA Expression by Growth Factors in Tumor Development and Progression

  2018cites this paper
• MicroRNA-128-3p-mediated depletion of Drosha promotes lung cancer cell migration

  2018cites this paper
• Alteration of MicroRNA Biogenesis Pathways in Cancers

  2018cites this paper
• Both serum and tissue Galectin‐1 levels are associated with adverse clinical features in neuroblastoma

  2018cites this paper
• A case of neuroblastoma in DICER1 syndrome: Chance finding or noncanonical causation?

  2018cites this paper
• PVT1 regulates the malignant behaviors of human glioma cells by targeting miR-190a-5p and miR-488-3p.

  2018cites this paper
• TITLE PAGE Title: Network modeling of microRNA-mRNA interactions in neuroblastoma tumorigenesis identifies miR-204 as a direct inhibitor of MYCN Authors: Chi

  2018cites this paper
• Computational analysis of genomic variants affecting predicted microRNA:target interactions in prostate cancer.

  2018cites this paper
• PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer

  2018cites this paper
• Persistent epigenetic modulation by radiation exposure/insults in mammalian cells

  2018cites this paper
• Two way controls of apoptotic regulators consign DmArgonaute-1 a better clasp on it

  2018cites this paper
• miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial–mesenchymal transition

  2018cites this paper
• Role of components of microRNA machinery in carcinogenesis.

  2018cites this paper
• Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN.

  2018cites this paper
• MicroRNAs deregulation in prostate cancer

  2017cites this paper
• Modeling bias and variation in the stochastic processes of small RNA sequencing

  2017cites this paper
• Molecular Genetics of Neuroblastoma

  2017cites this paper
• Molecular Approach to Neuroblastoma

  2017cites this paper
• microRNA-18a Promotes Cell Migration and Invasion Through Inhibiting Dicer l Expression in Hepatocellular Carcinoma In Vitro.

  2017cites this paper
• 11 Neuroblastoma and Whole Genome Searches

  2017cites this paper
• miR-10a and miR-204 as a Potential Prognostic Indicator in Low-Grade Gliomas

  2017cites this paper
• MicroRNA-140 mediates RB tumor suppressor function to control stem cell-like activity through interleukin-6

  2017cites this paper
• Post-Transcriptional Regulatory Mechanisms in the Control of Cell Identity

  2017cites this paper
• Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs

  2017cites this paper
• Racial Differences in Expression Levels of miRNA Machinery-Related Genes, Dicer, Drosha, DGCR8, and AGO2, in Asian Korean Papillary Thyroid Carcinoma and Comparative Validation Using the Cancer Genome Atlas

  2017cites this paper
• Atherosclerosis and Cancer; A Resemblance with Far-reaching Implications.

  2017cites this paper
• MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours

  2017cites this paper
• Involvement of miR-155/FOXO3a and miR-222/PTEN in acquired radioresistance of colorectal cancer cell line

  2017cites this paper
• The mutational landscape of MYCN, Lin28b and ALKF1174L driven murine neuroblastoma mimics human disease

  2017cites this paper
• DROSHA rs642321 Polymorphism Influence Susceptibility to Childhood Acute Lymphoblastic Leukemia: A Preliminary Report

  2017cites this paper
• Impaired expression of Drosha in breast cancer.

  2017cites this paper
• [Novel micro RNA-based therapies for the treatment of neuroblastoma].

  2016cites this paper
• Towards diagnostic application of non-coding RNAs in neuroblastoma

  2016cites this paper
• Role of Dicer as a prognostic predictor for survival in cancer patients: a systematic review with a meta-analysis

  2016cites this paper
• RNA-based gene circuits for cell regulation

  2016cites this paper
• MicroRNA Biogenesis and Hedgehog-Patched Signaling Cooperate to Regulate an Important Developmental Transition in Granule Cell Development

  2016cites this paper
• MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines

  2016cites this paper
• MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes

  2016cites this paper
• Dicer Gene Expression as a Prognostic Factor in Acute Lymphoblastic Leukemia and Chronic Lymphocytic Leukemia in Fars Province

  2016cites this paper
• Prognostic significance of Dicer expression in hepatocellular carcinoma

  2016cites this paper
• Cytoplasmic Drosha Is Aberrant in Precancerous Lesions of Gastric Carcinoma and Its Loss Predicts Worse Outcome for Gastric Cancer Patients

  2016cites this paper
• Bone Marrow Microenvironment Niche Regulates miR-221/222 in Acute Lymphoblastic Leukemia

  2016cites this paper
• Monocyte Chemoattractant Protein‐Induced Protein 1 Overexpression Modulates Transcriptome, Including MicroRNA, in Human Neuroblastoma Cells

  2016cites this paper
• MicroRNA biogenesis pathway genes polymorphisms and cancer risk: a systematic review and meta-analysis

  2016cites this paper
• als Role of MicroRNA in Endometrial Carcinoma

  2016cites this paper
• Action of HMGB1 on miR-221/222 cluster in neuroblastoma cell lines.

  2016cites this paper
• Role of MicroRNA in Endometrial Carcinoma

  2016cites this paper
• [Novel micro RNA-based therapies for the treatment of neuroblastoma].

  2016cites this paper
• Noncoding Transcripts as Cancer Biomarkers in Circulation

  2016cites this paper
• Action of HMGB 1 on miR-221 / 222 cluster in neuroblastoma cell lines

  2016cites this paper
• Dysregulation of microRNA biogenesis machinery in cancer

  2016cites this paper
• MicroRNA Therapeutics: Basic Principles, Barriers and Perspectives

  2015cites this paper
• MicroRNAs, cancer and ionizing radiation: Where are we?

  2015cites this paper
• Dysregulation of microRNA biogenesis and gene silencing in cancer

  2015cites this paper
• Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model

  2015cites this paper
• Revisiting Chaos Theorem to Understand the Nature of miRNAs in Response to Drugs of Abuse

  2015cites this paper